Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis

This study has been completed.
Sponsor:
Collaborators:
Novo Nordisk A/S
Mucoviscidose-ABCF2
Assistance Publique - Hôpitaux de Paris
Information provided by (Responsible Party):
Mukoviszidose Institut gGmbH
ClinicalTrials.gov Identifier:
NCT00662714
First received: April 17, 2008
Last updated: July 6, 2012
Last verified: July 2012